In a challenging market environment, Atossa Genetics Inc . (NASDAQ:ATOS) stock has touched a 52-week low, reaching a price level of $0.75. This latest dip underscores a period of volatility for the ...

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.

Nvidia remains vital to AI, with 87.5% upside potential. Learn why NVDA stock, priced at $118.50, could hit $222-$248.50 by ...

Why Are Technology Stocks Dragging the Market Down?

Nvidia remained above the 50-day moving average Friday. Late Tuesday, President Donald Trump announced a joint venture called ...

William T. Giles bought the dip in the bear and alcohol maker’s stock after Constellation reported a disappointing quarter.

Novo Nordisk's experimental obesity drug amycretin demonstrated promising weight loss results in an early-stage trial, with participants losing 22% of their body weight in 36 weeks. This news boosted ...

That's why the stock, trading just under 9 times forward earnings estimates right now, looks like a great bargain that value investors won't want to miss. Eli Lilly(NYSE ... great time to buy this ...